http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201001327-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
filingDate | 2009-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2011-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EA-201001327-A1 |
titleOfInvention | INJECTABLE COMPOSITIONS AND METHOD FOR THEIR PRODUCTION |
abstract | A pharmaceutically acceptable injectable formulation is disclosed that includes 3-hydroxy-2,4,6-trimethylpyridine, its pharmaceutically acceptable salts, esters, derivatives and polymorphic modifications for the treatment of ischemia, intraocular bleeding and macular degeneration. |
priorityDate | 2008-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID147625 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420731502 |
Total number of triples: 13.